188 related articles for article (PubMed ID: 38704385)
1. Biosynthetic production of anticoagulant heparin polysaccharides through metabolic and sulfotransferases engineering strategies.
Deng JQ; Li Y; Wang YJ; Cao YL; Xin SY; Li XY; Xi RM; Wang FS; Sheng JZ
Nat Commun; 2024 May; 15(1):3755. PubMed ID: 38704385
[TBL] [Abstract][Full Text] [Related]
2. The construction of a dual-functional strain that produces both polysaccharides and sulfotransferases.
Li X; Yu Y; Tang J; Gong B; Li W; Chen T; Zhou X
Biotechnol Lett; 2021 Sep; 43(9):1831-1844. PubMed ID: 34176028
[TBL] [Abstract][Full Text] [Related]
3. Bioengineering murine mastocytoma cells to produce anticoagulant heparin.
Gasimli L; Glass CA; Datta P; Yang B; Li G; Gemmill TR; Baik JY; Sharfstein ST; Esko JD; Linhardt RJ
Glycobiology; 2014 Mar; 24(3):272-80. PubMed ID: 24326668
[TBL] [Abstract][Full Text] [Related]
4. Metabolic engineering of non-pathogenic Escherichia coli strains for the controlled production of low molecular weight heparosan and size-specific heparosan oligosaccharides.
Roy A; Miyai Y; Rossi A; Paraswar K; Desai UR; Saijoh Y; Kuberan B
Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129765. PubMed ID: 33069832
[TBL] [Abstract][Full Text] [Related]
5. High cell density cultivation of a recombinant Escherichia coli strain expressing a 6-O-sulfotransferase for the production of bioengineered heparin.
Zhang J; Suflita M; Fiaschetti CM; Li G; Li L; Zhang F; Dordick JS; Linhardt RJ
J Appl Microbiol; 2015 Jan; 118(1):92-8. PubMed ID: 25362996
[TBL] [Abstract][Full Text] [Related]
6. High cell density cultivation of recombinant Escherichia coli strains expressing 2-O-sulfotransferase and C5-epimerase for the production of bioengineered heparin.
Zhang J; Suflita M; Li G; Zhong W; Li L; Dordick JS; Linhardt RJ; Zhang F
Appl Biochem Biotechnol; 2015 Mar; 175(6):2986-95. PubMed ID: 25586487
[TBL] [Abstract][Full Text] [Related]
7. Production of N-sulfated polysaccharides using yeast-expressed N-deacetylase/N-sulfotransferase-1 (NDST-1).
Saribaş AS; Mobasseri A; Pristatsky P; Chen X; Barthelson R; Hakes D; Wang J
Glycobiology; 2004 Dec; 14(12):1217-28. PubMed ID: 15253930
[TBL] [Abstract][Full Text] [Related]
8. Dissecting the substrate recognition of 3-O-sulfotransferase for the biosynthesis of anticoagulant heparin.
Moon AF; Xu Y; Woody SM; Krahn JM; Linhardt RJ; Liu J; Pedersen LC
Proc Natl Acad Sci U S A; 2012 Apr; 109(14):5265-70. PubMed ID: 22431632
[TBL] [Abstract][Full Text] [Related]
9. Improvement of the stability and catalytic efficiency of heparan sulfate N-sulfotransferase for preparing N-sulfated heparosan.
Xi X; Hu L; Huang H; Wang Y; Xu R; Du G; Chen J; Kang Z
J Ind Microbiol Biotechnol; 2023 Feb; 50(1):. PubMed ID: 37327079
[TBL] [Abstract][Full Text] [Related]
10. Bioengineered Chinese hamster ovary cells with Golgi-targeted 3-O-sulfotransferase-1 biosynthesize heparan sulfate with an antithrombin-binding site.
Datta P; Li G; Yang B; Zhao X; Baik JY; Gemmill TR; Sharfstein ST; Linhardt RJ
J Biol Chem; 2013 Dec; 288(52):37308-18. PubMed ID: 24247246
[TBL] [Abstract][Full Text] [Related]
11. Expression and secretion of glycosylated heparin biosynthetic enzymes using Komagataella pastoris.
Englaender JA; Zhu Y; Shirke AN; Lin L; Liu X; Zhang F; Gross RA; Koffas MA; Linhardt RJ
Appl Microbiol Biotechnol; 2017 Apr; 101(7):2843-2851. PubMed ID: 27975137
[TBL] [Abstract][Full Text] [Related]
12. Use of biosynthetic enzymes in heparin and heparan sulfate synthesis.
Chappell EP; Liu J
Bioorg Med Chem; 2013 Aug; 21(16):4786-92. PubMed ID: 23313092
[TBL] [Abstract][Full Text] [Related]
13. Control of the heparosan N-deacetylation leads to an improved bioengineered heparin.
Wang Z; Yang B; Zhang Z; Ly M; Takieddin M; Mousa S; Liu J; Dordick JS; Linhardt RJ
Appl Microbiol Biotechnol; 2011 Jul; 91(1):91-9. PubMed ID: 21484210
[TBL] [Abstract][Full Text] [Related]
14. High cell density cultivation of a recombinant E. coli strain expressing a key enzyme in bioengineered heparin production.
Restaino OF; Bhaskar U; Paul P; Li L; De Rosa M; Dordick JS; Linhardt RJ
Appl Microbiol Biotechnol; 2013 May; 97(9):3893-900. PubMed ID: 23318839
[TBL] [Abstract][Full Text] [Related]
15. Production methods for heparosan, a precursor of heparin and heparan sulfate.
Chavaroche AA; van den Broek LA; Eggink G
Carbohydr Polym; 2013 Mar; 93(1):38-47. PubMed ID: 23465899
[TBL] [Abstract][Full Text] [Related]
16. Advancements in heparosan production through metabolic engineering and improved fermentation.
Sheng LL; Cai YM; Li Y; Huang SL; Sheng JZ
Carbohydr Polym; 2024 May; 331():121881. PubMed ID: 38388039
[TBL] [Abstract][Full Text] [Related]
17. The effect of precursor structures on the action of glucosaminyl 3-O-sulfotransferase-1 and the biosynthesis of anticoagulant heparan sulfate.
Zhang L; Lawrence R; Schwartz JJ; Bai X; Wei G; Esko JD; Rosenberg RD
J Biol Chem; 2001 Aug; 276(31):28806-13. PubMed ID: 11375390
[TBL] [Abstract][Full Text] [Related]
18. Combinatorial one-pot chemoenzymatic synthesis of heparin.
Bhaskar U; Li G; Fu L; Onishi A; Suflita M; Dordick JS; Linhardt RJ
Carbohydr Polym; 2015 May; 122():399-407. PubMed ID: 25817684
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a heparan sulfate 3-O-sulfotransferase-5, an enzyme synthesizing a tetrasulfated disaccharide.
Mochizuki H; Yoshida K; Gotoh M; Sugioka S; Kikuchi N; Kwon YD; Tawada A; Maeyama K; Inaba N; Hiruma T; Kimata K; Narimatsu H
J Biol Chem; 2003 Jul; 278(29):26780-7. PubMed ID: 12740361
[TBL] [Abstract][Full Text] [Related]
20. The putative heparin-specific N-acetylglucosaminyl N-Deacetylase/N-sulfotransferase also occurs in non-heparin-producing cells.
Toma L; Berninsone P; Hirschberg CB
J Biol Chem; 1998 Aug; 273(35):22458-65. PubMed ID: 9712870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
